Stroke
Conditions
Keywords
Stroke, Gait, Stride Management Assist, Mild-moderate Stroke, post 30 days or longer
Brief summary
Hypothesis/Specific Aims: The purpose of this study is to determine the effect of training with the Stride Management Assist (SMA) device vs. Impairment based physical therapy (IPT) on descending corticospinal drive to the lower limb muscles in patients post stroke. The investigators hypothesize that long-term SMA use would strengthen the connections between the motor areas of the brain and the lower limbs. Specifically, individuals in the SMA group will show higher corticospinal excitability of the lower limb muscles compared to those in the IPT group.
Detailed description
This is a randomized control trial comparing task specific training with the Stride Management Assist (SMA) device verses an impairment based physical therapy (IPT) approach on functional walking ability in outpatient stroke rehabilitation. Participants between the ages of 18-80 and who are 30 days or greater post stroke will be included. This SMA robotic device assists hip flexion and extension, for each side independently. It is controlled through software run on a tablet. The device weighs 2.8 kgs, and has 2 brushless direct current motors running on a rechargeable lithium ion battery. It comes in 3 sizes (small, medium and large). It is worn around like a belt with the motors near the hips and straps on the thighs. The SMA device allows users to increase their stride length by providing assist with the motors in flexion and extension. This device is 1) simple to use in the clinical setting; 2) easily adjustable to alter according to the requirements of each subject; and, 3) can quantify the amount of assistance required to facilitate walking patterns. Participants post stroke 30 days or greater will be recruited from inpatient, day rehabilitation and outpatient clinics. Participants will be scheduled for 18 Sessions of outpatient physical therapy plus 3 sessions of testing. The amount of sessions provided will be dependent upon compatibility with the device and ability to tolerate the device. A participant will continue with each session of the study as deemed appropriate by research staff. * A. Phase I. (session 0): After consenting, subjects will undergo a physical evaluation and screening exam by a licensed physical therapist. If they meet study criteria, they will be randomly placed into either the SMA group or the IPT group using a random number generator and they will be entered into the study. Once they are enrolled, baseline outcome measures will be assessed by a blinded research physical therapist. * B. Phase II. (sessions 1-9): * Stride Management Assist Group: Treatment consists of 30 minutes high intensity gait training with device, 15 minutes functional mobility with device. * Impairment Based Physical Therapy Group: Treatment will be divided into: 15 min balance training, 15 minutes functional mobility (transfers, strength or flexibility training) and 15 min high intensity gait training * C. Phase III. (session 10): Mid treatment assessment. Outcome measures will be assessed by a blinded research physical therapist. * D. Phase II. (sessions 11-19): * Stride Management Assist Group: Treatment consists of 30 minutes high intensity gait training with device, 15 minutes functional mobility with device. * Impairment Based Physical Therapy Group: Treatment will be divided into: 15 min balance training, 15 minutes functional mobility (transfers, strength or flexibility training) and 15 min high intensity gait training * E. Phase IV. (session 20): Post Testing. Outcome measures will be assessed by a blinded research physical therapist. All testing and training sessions will be under the supervision of a licensed physical therapist. All subjects will be permitted to stop physical activity or rest at any time during the study. Adverse events will be recorded. The investigators anticipate this study will help determine if the Stride Management Assist is a practical option to better strengthen the connections between the brain and the lower limbs. The investigators do not foresee any potential pitfalls.
Interventions
Participants will participate in 18 sessions of outpatient physical therapy + 3 sessions of testing for up to 8 weeks. Assessment (strength, flexibility, balance, sensation, endurance, transfers, gait. Treatment consists of 30 minutes high intensity gait training with device, 15 minutes functional mobility with device.
Participants participate in 18 weeks of outpatient physical therapy + 3 assessment sessions. Assessment (strength, flexibility, balance, sensation, endurance, transfers, gait). Treatment will be divided into: 15 min balance training, 15 minutes functional mobility (transfers, strength or flexibility training) and 15 min high intensity gait training
Sponsors
Study design
Masking description
A blinded research physical therapist will test the outcome measure at baseline, Mid Testing after Session 9 , at Post Testing after Session 18 and at 3 month follow up testing after Session 18.
Intervention model description
The SMA group (task specific training) will be trained to simulate the demands of overground walking. The impairment based group will match the SMA group in intensity but will be focused on balance and other functional goals rather than explicitly on walking. The rationale of this study is to assess task specific training with SMA vs. impairment based training. To this end, we will use the Stride Management Assist device by Honda Corporation and compare it to impairment based physical therapy in outpatient sessions.
Eligibility
Inclusion criteria
* ≥ 30-days post stroke * Initial gait speed of \> 0.4 m/s and \< 0.8 m/s * Adequate cognitive function (MMSE score \>17) * Subject is willing to be randomized to the control group or the treatment group. * Ability to sit unsupported for 30 seconds * Ability to walk at least 10m with maximum 1 person assist, * Ability to follow a three-step command * Physician approval for patient participation * Living in the community post-stroke with ability to travel to the intervention site to participate in the outpatient program and able to perform the home exercise program in the residential facility. * Willing to carry wireless body sensors through the period of the study and to follow-up time period, post inpatient stroke, cardiac, pulmonary, or any other lower extremity physical rehabilitation * ≥ 90 days post major orthopedic surgery (i.e. hip, knee, and/or ankle joint replacement) * ≥ 6 months post coronary artery bypass grafting (CABG) or cardiac valve procedure * Able and willing to give written consent and comply with study procedures, including follow-up visits * Cannot not be participating in any other structured outpatient or home health physical therapy program
Exclusion criteria
* Serious cardiac conditions (hospitalization for myocardial infarction or heart surgery within 3 months, history of congestive heart failure, documented serious and unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living) * Severe arthritis or orthopedic problems that limit passive ranges of motion (ROM) of lower extremity (knee flexion contracture of \> 10°, knee flexion ROM \< 90°, hip flexion contracture \> 25°, and ankle plantar flexion contracture \> 15 * Serious medical conditions including myocardial infarction or heart surgery within 3 months, history of congestive heart failure, documented serious and unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living, Severe hypertension, severe weight bearing pain, life expectancy less than one year * Preexisting neurological disorders such as Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), dementia * History of major head trauma, Lower extremity amputation, Non-healing ulcers of a lower extremity, Renal dialysis or end stage liver disease, Legal blindness or severe visual impairment, a history of significant psychiatric illness * History of unexplained, recurring headaches, epilepsy/seizures/skull fractures or skull deficits * Medications that lower seizure threshold * History of concussion in last 6 months * Subject is pregnant, nursing or planning a pregnancy * Inability to travel 3 times per week for outpatient training programs * Participating in another clinical trial that, according to the Principal Investigator, is likely to affect study outcome or confound results
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in 10 Meter Walk Test From Baseline in Gait Speed | Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up) | Measure of self selected and fast walking speeds by measuring the time it takes an individual to walk 10 meters. The test is performed using a flying start, patient walks 10 meters (33 ft) and the time is measured when the leading foot crosses the start line and the finish line. The instructions are: Please walk this distance at your normal pace when I say go. and repeated Please walk this distance as fast as you can safely when I say go. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Numeric Pain Rating Scale (NPRS) | Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up) | The NPRS is an 11-point scale from 0-10 where patients verbally select a value that is most in line with the intensity of pain that they have experienced in the last 24 hours from 0 (no pain) to 10 (the most intense pain imaginable). |
| Stroke Specific Quality of Life Scale (SS-QOL) | Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up) | A 49 item assessment grouped into 12 domains of health-related quality of life in stroke survivors; including areas of mobility, energy, upper extremity function, work and productivity, mood, self-care, social roles, family roles, vision, language, thinking, personality. Each individual domain consists of 3 to 10 items that are averaged to generate an overall score, each item is rated on a 5- point Likert scale, with a minimum value of 1 (meaning the worst outcome) and a maximum value of 5 (meaning the best outcome). Domains scores (non-weighted average of item scores) and a summary score (non-weighted average of all 12 domain scores) are computed. Summary scores range from 49-245, with higher scores indicating better functioning. |
| The Modified Falls Efficacy Scale (mFES) | Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up) | 14 item questionnaire assessing individuals' confidence in their ability to perform tasks without falling. Individuals rate their confidence from 0 (not confident at all) to 100 (completely confident). |
| Activities-Specific Balance Confidence Scale (ABC) | Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up) | ABC is a 16-item self-report measure in which patients rate their balance confidence in performing various ambulatory activities without falling. Items are rated on a scale ranging from 0-100, with zero representing no confidence and 100 representing complete confidence. |
| Participants Receiving Transcranial Magnetic Stimulation (TMS) | Session 0 (initial visit);Session 20 (between 6-8 weeks) | To compare the effect of training on the connections between the brain and leg muscles (descending corticomotor drive) using a non-invasive brain stimulation called transcranial magnetic stimulation (TMS). TMS is a safe, non-invasive, painless method of brain stimulation that has been widely used to study the physiology of the representations of muscles in the motor cortex in healthy and neurologically disordered individuals13. Very short duration (\< 1 ms) magnetic pulses are applied via an insulated wire coil placed on the intact scalp overlaying the motor cortical area projecting to a target muscle. Each pulse induces a motor evoked potential (MEP) in a target muscle that can be readily monitored by recording Electromyogram (EMG) from that muscle. A figure-of-eight or double cone coil is typically used to deliver focal magnetic pulses to a number of scalp sites over the cortical area representing a muscle of interest. |
| Change in 6 Minute Walk Test From Baseline in Distance (6MWT) | Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up) | The 6 Minute Walk Test (6MWT) is a test of endurance, by measuring the distance a subject can walk indoors on a flat, hard surface in a period of 6 minutes, using assistive devices, as necessary.The distance is measured with a measuring wheel. The instructions are Walk covering as much ground as you can in 6 min. You can stop to sit or stand if needed, but time will keep running. The change in the distance walked in the 6-minute walk can be used to evaluate the efficacy of an exercise-training program or to trace the natural history of change in exercise capacity over time. The 6MWT is measured in meters. |
| Berg Balance Scale (BBS) | Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up) | The BBS is a 14-item objective measure designed to assess static balance and fall risk in adult populations and is a well-accepted measure in the stroke literature. The functional activities that are assessed include sitting and standing balance during transfers, altered base of support, reaching, turning, eyes open and closed. Each item is scored from 0 to 4 points. The maximum score is 56 points. A score from 0 to 20 represents balance impairment, 21 to 40 represents acceptable balance, and 41-56 represents good balance. The minimal detectable change score for individuals with acute stroke is 6.9 points16 and 4.66 points in chronic stroke17. |
| Patient Health Questionnaire-9 (PHQ-9) | Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up) | PHQ-9 is a 9-item self-report questionnaire designed to diagnose both the presence of depressive symptoms as well as to characterize the severity of depression. A single question rates how difficult problems have made it to do work, take care of things at home or get along with other people using a 4 level scale (not difficult at all to extremely difficult). Each item is scored from 0-3; total scores may be 0-27, with higher scores representing increased severity of depression. |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Stride Management Assist (SMA) System Participants will be randomized into either the SMA group or impairment based (IPT) group.
The Stride Management Assist (SMA) System: Participants will participate in 18 sessions of outpatient physical therapy + 3 sessions of testing for up to 8 weeks. Assessment (strength, flexibility, balance, sensation, endurance, transfers, gait. Treatment consists of 30 minutes high intensity gait training with device, 15 minutes functional mobility with device. | 26 |
| Impairment Based Therapy Impairment based therapy will include traditional functional mobility training physical therapy.
Impairment based therapy: Participants participate in 18 weeks of outpatient physical therapy + 3 assessment sessions. Assessment (strength, flexibility, balance, sensation, endurance, transfers, gait). Treatment will be divided into: 15 min balance training, 15 minutes functional mobility (transfers, strength or flexibility training) and 15 min high intensity gait training | 27 |
| Total | 53 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Withdrawal by Subject | 1 | 2 |
Baseline characteristics
| Characteristic | Total | Impairment Based Therapy | Stride Management Assist (SMA) System |
|---|---|---|---|
| 10 Meter Walk Test | 0.68 meters per second STANDARD_DEVIATION 0.1 | 0.65 meters per second STANDARD_DEVIATION 0.1 | 0.7 meters per second STANDARD_DEVIATION 0.1 |
| Age, Categorical <=18 years | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical >=65 years | 17 Participants | 11 Participants | 6 Participants |
| Age, Categorical Between 18 and 65 years | 36 Participants | 16 Participants | 20 Participants |
| Age, Continuous | 61 years STANDARD_DEVIATION 11.5 | 62 years STANDARD_DEVIATION 13 | 60 years STANDARD_DEVIATION 10 |
| Race and Ethnicity Not Collected | 0 Participants | — | — |
| Region of Enrollment United States | 50 participants | 25 participants | 25 participants |
| Sex: Female, Male Female | 17 Participants | 9 Participants | 8 Participants |
| Sex: Female, Male Male | 33 Participants | 16 Participants | 17 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 25 | 0 / 25 |
| other Total, other adverse events | 0 / 25 | 0 / 25 |
| serious Total, serious adverse events | 0 / 25 | 0 / 25 |
Outcome results
Change in 10 Meter Walk Test From Baseline in Gait Speed
Measure of self selected and fast walking speeds by measuring the time it takes an individual to walk 10 meters. The test is performed using a flying start, patient walks 10 meters (33 ft) and the time is measured when the leading foot crosses the start line and the finish line. The instructions are: Please walk this distance at your normal pace when I say go. and repeated Please walk this distance as fast as you can safely when I say go.
Time frame: Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up)
Population: One subject from SMA group and 2 from impairment based therapy group dropped due to scheduling conflicts prior to starting any training.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Stride Management Assist (SMA) System | Change in 10 Meter Walk Test From Baseline in Gait Speed | Baseline Assessment | 0.7051 meters per second | Standard Deviation 0.122677 |
| Stride Management Assist (SMA) System | Change in 10 Meter Walk Test From Baseline in Gait Speed | Mid Training Assessment | 0.8544 meters per second | Standard Deviation 0.202805061 |
| Stride Management Assist (SMA) System | Change in 10 Meter Walk Test From Baseline in Gait Speed | Post Training Assessment | 0.9566 meters per second | Standard Deviation 0.20176847 |
| Stride Management Assist (SMA) System | Change in 10 Meter Walk Test From Baseline in Gait Speed | 3 Month Post Training Assessment | 0.9439 meters per second | Standard Deviation 0.226535699 |
| Impairment Based Therapy | Change in 10 Meter Walk Test From Baseline in Gait Speed | 3 Month Post Training Assessment | 0.8085 meters per second | Standard Deviation 0.169381067 |
| Impairment Based Therapy | Change in 10 Meter Walk Test From Baseline in Gait Speed | Baseline Assessment | 0.6606 meters per second | Standard Deviation 0.12067815 |
| Impairment Based Therapy | Change in 10 Meter Walk Test From Baseline in Gait Speed | Post Training Assessment | 0.8376 meters per second | Standard Deviation 0.191048354 |
| Impairment Based Therapy | Change in 10 Meter Walk Test From Baseline in Gait Speed | Mid Training Assessment | 0.7547 meters per second | Standard Deviation 0.16119851 |
Activities-Specific Balance Confidence Scale (ABC)
ABC is a 16-item self-report measure in which patients rate their balance confidence in performing various ambulatory activities without falling. Items are rated on a scale ranging from 0-100, with zero representing no confidence and 100 representing complete confidence.
Time frame: Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up)
Population: One subject from SMA group and 2 from impairment based therapy group dropped due to scheduling conflicts prior to starting any training.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Stride Management Assist (SMA) System | Activities-Specific Balance Confidence Scale (ABC) | Pre Training Assessment | 66.7625 units on a scale | Standard Deviation 18.00944 |
| Stride Management Assist (SMA) System | Activities-Specific Balance Confidence Scale (ABC) | Mid Training Assessment | 73.2067 units on a scale | Standard Deviation 15.44828 |
| Stride Management Assist (SMA) System | Activities-Specific Balance Confidence Scale (ABC) | Post Training Assessment | 79.1630 units on a scale | Standard Deviation 13.30643987 |
| Stride Management Assist (SMA) System | Activities-Specific Balance Confidence Scale (ABC) | 3 Month Post Training Assessment | 81.6292 units on a scale | Standard Deviation 11.41238 |
| Impairment Based Therapy | Activities-Specific Balance Confidence Scale (ABC) | 3 Month Post Training Assessment | 78.3749 units on a scale | Standard Deviation 13.50986798 |
| Impairment Based Therapy | Activities-Specific Balance Confidence Scale (ABC) | Pre Training Assessment | 67.6472 units on a scale | Standard Deviation 17.7136527 |
| Impairment Based Therapy | Activities-Specific Balance Confidence Scale (ABC) | Post Training Assessment | 77.99 units on a scale | Standard Deviation 13.3571932 |
| Impairment Based Therapy | Activities-Specific Balance Confidence Scale (ABC) | Mid Training Assessment | 70.4443 units on a scale | Standard Deviation 17.4234304 |
Berg Balance Scale (BBS)
The BBS is a 14-item objective measure designed to assess static balance and fall risk in adult populations and is a well-accepted measure in the stroke literature. The functional activities that are assessed include sitting and standing balance during transfers, altered base of support, reaching, turning, eyes open and closed. Each item is scored from 0 to 4 points. The maximum score is 56 points. A score from 0 to 20 represents balance impairment, 21 to 40 represents acceptable balance, and 41-56 represents good balance. The minimal detectable change score for individuals with acute stroke is 6.9 points16 and 4.66 points in chronic stroke17.
Time frame: Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up)
Population: One subject dropped out at baseline screening, prior to assignment to any group. One subject from SMA group and 2 from impairment based therapy group dropped due to scheduling conflicts prior to starting any training.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Stride Management Assist (SMA) System | Berg Balance Scale (BBS) | Pre Training Assessment | 44 units on a scale, each item scored 0-4 | Standard Deviation 6 |
| Stride Management Assist (SMA) System | Berg Balance Scale (BBS) | Mid Training Assessment | 46 units on a scale, each item scored 0-4 | Standard Deviation 6 |
| Stride Management Assist (SMA) System | Berg Balance Scale (BBS) | Post Training Assessment | 48 units on a scale, each item scored 0-4 | Standard Deviation 4 |
| Stride Management Assist (SMA) System | Berg Balance Scale (BBS) | 3 Month Post Training Assessment | 48 units on a scale, each item scored 0-4 | Standard Deviation 4 |
| Impairment Based Therapy | Berg Balance Scale (BBS) | 3 Month Post Training Assessment | 48 units on a scale, each item scored 0-4 | Standard Deviation 3 |
| Impairment Based Therapy | Berg Balance Scale (BBS) | Pre Training Assessment | 44 units on a scale, each item scored 0-4 | Standard Deviation 4 |
| Impairment Based Therapy | Berg Balance Scale (BBS) | Post Training Assessment | 48 units on a scale, each item scored 0-4 | Standard Deviation 3 |
| Impairment Based Therapy | Berg Balance Scale (BBS) | Mid Training Assessment | 46 units on a scale, each item scored 0-4 | Standard Deviation 4 |
Change in 6 Minute Walk Test From Baseline in Distance (6MWT)
The 6 Minute Walk Test (6MWT) is a test of endurance, by measuring the distance a subject can walk indoors on a flat, hard surface in a period of 6 minutes, using assistive devices, as necessary.The distance is measured with a measuring wheel. The instructions are Walk covering as much ground as you can in 6 min. You can stop to sit or stand if needed, but time will keep running. The change in the distance walked in the 6-minute walk can be used to evaluate the efficacy of an exercise-training program or to trace the natural history of change in exercise capacity over time. The 6MWT is measured in meters.
Time frame: Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up)
Population: One subject from SMA group and 2 from impairment based therapy group dropped due to scheduling conflicts prior to starting any training.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Stride Management Assist (SMA) System | Change in 6 Minute Walk Test From Baseline in Distance (6MWT) | Pre Training Assessment | 874.6067 units on a scale | Standard Deviation 220.4362 |
| Stride Management Assist (SMA) System | Change in 6 Minute Walk Test From Baseline in Distance (6MWT) | Mid Treatment Assessment | 1140.5040 units on a scale | Standard Deviation 364.1122684 |
| Stride Management Assist (SMA) System | Change in 6 Minute Walk Test From Baseline in Distance (6MWT) | Post Training Assessment | 1268.24 units on a scale | Standard Deviation 344.0931699 |
| Stride Management Assist (SMA) System | Change in 6 Minute Walk Test From Baseline in Distance (6MWT) | 3 Month Post Training Assessment | 1230.3088 units on a scale | Standard Deviation 375.9471237 |
| Impairment Based Therapy | Change in 6 Minute Walk Test From Baseline in Distance (6MWT) | 3 Month Post Training Assessment | 1035.1053 units on a scale | Standard Deviation 185.5663909 |
| Impairment Based Therapy | Change in 6 Minute Walk Test From Baseline in Distance (6MWT) | Pre Training Assessment | 794.33 units on a scale | Standard Deviation 151.703575 |
| Impairment Based Therapy | Change in 6 Minute Walk Test From Baseline in Distance (6MWT) | Post Training Assessment | 1065.5567 units on a scale | Standard Deviation 227.1440369 |
| Impairment Based Therapy | Change in 6 Minute Walk Test From Baseline in Distance (6MWT) | Mid Treatment Assessment | 963.1633 units on a scale | Standard Deviation 227.048913 |
Numeric Pain Rating Scale (NPRS)
The NPRS is an 11-point scale from 0-10 where patients verbally select a value that is most in line with the intensity of pain that they have experienced in the last 24 hours from 0 (no pain) to 10 (the most intense pain imaginable).
Time frame: Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up)
Population: One subject dropped out at baseline screening, prior to assignment to any group. One subject from SMA group and 2 from impairment based therapy group dropped due to scheduling conflicts prior to starting any training.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Stride Management Assist (SMA) System | Numeric Pain Rating Scale (NPRS) | Pre Training Assessment | 0.733336 units on a scale | Standard Deviation 1.589901 |
| Stride Management Assist (SMA) System | Numeric Pain Rating Scale (NPRS) | Mid Training Assessment | 1.166668 units on a scale | Standard Deviation 1.83081 |
| Stride Management Assist (SMA) System | Numeric Pain Rating Scale (NPRS) | Post Training Assessment | 0.879996 units on a scale | Standard Deviation 1.83081 |
| Stride Management Assist (SMA) System | Numeric Pain Rating Scale (NPRS) | 3 Month Post Training Assessment | 1.568606 units on a scale | Standard Deviation 2.136855 |
| Impairment Based Therapy | Numeric Pain Rating Scale (NPRS) | 3 Month Post Training Assessment | 0.587721053 units on a scale | Standard Deviation 1.235250407 |
| Impairment Based Therapy | Numeric Pain Rating Scale (NPRS) | Pre Training Assessment | 0.680004 units on a scale | Standard Deviation 1.67631206 |
| Impairment Based Therapy | Numeric Pain Rating Scale (NPRS) | Post Training Assessment | 0.599995 units on a scale | Standard Deviation 1.45295656 |
| Impairment Based Therapy | Numeric Pain Rating Scale (NPRS) | Mid Training Assessment | 0.72458 units on a scale | Standard Deviation 1.61792765 |
Participants Receiving Transcranial Magnetic Stimulation (TMS)
To compare the effect of training on the connections between the brain and leg muscles (descending corticomotor drive) using a non-invasive brain stimulation called transcranial magnetic stimulation (TMS). TMS is a safe, non-invasive, painless method of brain stimulation that has been widely used to study the physiology of the representations of muscles in the motor cortex in healthy and neurologically disordered individuals13. Very short duration (\< 1 ms) magnetic pulses are applied via an insulated wire coil placed on the intact scalp overlaying the motor cortical area projecting to a target muscle. Each pulse induces a motor evoked potential (MEP) in a target muscle that can be readily monitored by recording Electromyogram (EMG) from that muscle. A figure-of-eight or double cone coil is typically used to deliver focal magnetic pulses to a number of scalp sites over the cortical area representing a muscle of interest.
Time frame: Session 0 (initial visit);Session 20 (between 6-8 weeks)
Population: One subject dropped before being assigned to a group. One subject from SMA group and 2 from impairment based therapy group dropped due to scheduling conflicts prior to starting any training.
| Arm | Measure | Group | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Stride Management Assist (SMA) System | Participants Receiving Transcranial Magnetic Stimulation (TMS) | Session 0 | 15 Participants |
| Stride Management Assist (SMA) System | Participants Receiving Transcranial Magnetic Stimulation (TMS) | Session 20 | 15 Participants |
| Impairment Based Therapy | Participants Receiving Transcranial Magnetic Stimulation (TMS) | Session 0 | 15 Participants |
| Impairment Based Therapy | Participants Receiving Transcranial Magnetic Stimulation (TMS) | Session 20 | 15 Participants |
Patient Health Questionnaire-9 (PHQ-9)
PHQ-9 is a 9-item self-report questionnaire designed to diagnose both the presence of depressive symptoms as well as to characterize the severity of depression. A single question rates how difficult problems have made it to do work, take care of things at home or get along with other people using a 4 level scale (not difficult at all to extremely difficult). Each item is scored from 0-3; total scores may be 0-27, with higher scores representing increased severity of depression.
Time frame: Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up)
Population: One subject dropped out at baseline screening, prior to assignment to any group. One subject from SMA group and 2 from impairment based therapy group dropped due to scheduling conflicts prior to starting any training.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Stride Management Assist (SMA) System | Patient Health Questionnaire-9 (PHQ-9) | Pre Training Assessment | 3.72 units on a scale | Standard Deviation 3.553402 |
| Stride Management Assist (SMA) System | Patient Health Questionnaire-9 (PHQ-9) | Mid Training Assessment | 2.88 units on a scale | Standard Deviation 2.437895 |
| Stride Management Assist (SMA) System | Patient Health Questionnaire-9 (PHQ-9) | Post Training Assessment | 2.32 units on a scale | Standard Deviation 2.267891826 |
| Stride Management Assist (SMA) System | Patient Health Questionnaire-9 (PHQ-9) | 3 Month Post Training Assessment | 3.352941 units on a scale | Standard Deviation 2.935583 |
| Impairment Based Therapy | Patient Health Questionnaire-9 (PHQ-9) | 3 Month Post Training Assessment | 2.631578947 units on a scale | Standard Deviation 2.8908000088 |
| Impairment Based Therapy | Patient Health Questionnaire-9 (PHQ-9) | Pre Training Assessment | 3.68 units on a scale | Standard Deviation 4.31779265 |
| Impairment Based Therapy | Patient Health Questionnaire-9 (PHQ-9) | Post Training Assessment | 2.16 units on a scale | Standard Deviation 3.15805848 |
| Impairment Based Therapy | Patient Health Questionnaire-9 (PHQ-9) | Mid Training Assessment | 3.12 units on a scale | Standard Deviation 4.12633817 |
Stroke Specific Quality of Life Scale (SS-QOL)
A 49 item assessment grouped into 12 domains of health-related quality of life in stroke survivors; including areas of mobility, energy, upper extremity function, work and productivity, mood, self-care, social roles, family roles, vision, language, thinking, personality. Each individual domain consists of 3 to 10 items that are averaged to generate an overall score, each item is rated on a 5- point Likert scale, with a minimum value of 1 (meaning the worst outcome) and a maximum value of 5 (meaning the best outcome). Domains scores (non-weighted average of item scores) and a summary score (non-weighted average of all 12 domain scores) are computed. Summary scores range from 49-245, with higher scores indicating better functioning.
Time frame: Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up)
Population: One subject dropped out at baseline screening, prior to assignment to any group. One subject from SMA group and 2 from impairment based therapy group dropped due to scheduling conflicts prior to starting any training.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Stride Management Assist (SMA) System | Stroke Specific Quality of Life Scale (SS-QOL) | Pre Training Assessment | 198.16 units on a scale | Standard Deviation 21.30665 |
| Stride Management Assist (SMA) System | Stroke Specific Quality of Life Scale (SS-QOL) | Mid Training Assessment | 204.8 units on a scale | Standard Deviation 23.02897 |
| Stride Management Assist (SMA) System | Stroke Specific Quality of Life Scale (SS-QOL) | Post Training Assessment | 205.6 units on a scale | Standard Deviation 24.54248018 |
| Stride Management Assist (SMA) System | Stroke Specific Quality of Life Scale (SS-QOL) | 3 Month Post Training Assessment | 200.3529 units on a scale | Standard Deviation 25.22633 |
| Impairment Based Therapy | Stroke Specific Quality of Life Scale (SS-QOL) | 3 Month Post Training Assessment | 211.5789474 units on a scale | Standard Deviation 27.31771055 |
| Impairment Based Therapy | Stroke Specific Quality of Life Scale (SS-QOL) | Pre Training Assessment | 193.84 units on a scale | Standard Deviation 25.4945746 |
| Impairment Based Therapy | Stroke Specific Quality of Life Scale (SS-QOL) | Post Training Assessment | 211.72 units on a scale | Standard Deviation 23.3158029 |
| Impairment Based Therapy | Stroke Specific Quality of Life Scale (SS-QOL) | Mid Training Assessment | 205.36 units on a scale | Standard Deviation 23.5741384 |
The Modified Falls Efficacy Scale (mFES)
14 item questionnaire assessing individuals' confidence in their ability to perform tasks without falling. Individuals rate their confidence from 0 (not confident at all) to 100 (completely confident).
Time frame: Baseline Assessment (Visit 1), Mid Training Assessment (Visit 10), Post Training Assessment (Visit 18), 3 Month Post Training Assessment (3 Month Follow-up)
Population: One subject dropped out at baseline screening, prior to assignment to any group. One subject from SMA group and 2 from impairment based therapy group dropped due to scheduling conflicts prior to starting any training.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Stride Management Assist (SMA) System | The Modified Falls Efficacy Scale (mFES) | Pre Training Assessment | 8.3803 units on a scale | Standard Deviation 1.448756 |
| Stride Management Assist (SMA) System | The Modified Falls Efficacy Scale (mFES) | Mid Training Assessment | 8.9228 units on a scale | Standard Deviation 1.061062 |
| Stride Management Assist (SMA) System | The Modified Falls Efficacy Scale (mFES) | Post Training Assessment | 9.0971 units on a scale | Standard Deviation 0.937882386 |
| Stride Management Assist (SMA) System | The Modified Falls Efficacy Scale (mFES) | 3 Month Post Training Assessment | 9.2941 units on a scale | Standard Deviation 0.785258 |
| Impairment Based Therapy | The Modified Falls Efficacy Scale (mFES) | 3 Month Post Training Assessment | 9.078111111 units on a scale | Standard Deviation 1.094633589 |
| Impairment Based Therapy | The Modified Falls Efficacy Scale (mFES) | Pre Training Assessment | 8.4426 units on a scale | Standard Deviation 1.20545002 |
| Impairment Based Therapy | The Modified Falls Efficacy Scale (mFES) | Post Training Assessment | 9.075176 units on a scale | Standard Deviation 0.9848385 |
| Impairment Based Therapy | The Modified Falls Efficacy Scale (mFES) | Mid Training Assessment | 8.719996 units on a scale | Standard Deviation 0.98649669 |